NewSquare Capital’s BioLife Solutions BLFS Stock Holding History

NewSquare Capital’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-45	Closed	-$969	–	314
2025 Q2	$969	Buy	+45	New	+$1.01K	﹤0.01%	1056

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

NewSquare Capital's BLFS Position: Q3 2025 in Review

NewSquare Capital sold out of BioLife Solutions (BLFS) in Q3 2025, closing a stake of 45 shares — an estimated $969 sold.

NewSquare Capital first reported a position in BLFS in Q2 2025 and held it in 1 quarter. The position peaked at $969 in Q2 2025. 192 funds tracked by Wall St. Rank hold BLFS as of Q3 2025.

NewSquare Capital reported no remaining BioLife Solutions position as of Q3 2025 after selling out during the quarter.
NewSquare Capital sold 45 BioLife Solutions shares in Q3 2025, an estimated $969.
NewSquare Capital first reported a position in BioLife Solutions in Q2 2025 and held it in 1 quarter.
NewSquare Capital's BioLife Solutions position peaked at $969 in Q2 2025.
192 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2025.

Based on NewSquare Capital's 13F filing for Q3 2025, filed 12 Nov 2025.